Back

detimedac® 200mg

Product specifications
  • Active Ingredient (INN)
    Dacarbazine citrace
  • Manufacturer
    Medac
  • Country of manufacture
    Germany
  • Form/Dose
    200 mg powder for solution for I.V. injection/infusion vials №10
  • Concentration
  • Excipients
  • Manufacturing site GMP status
  • US FDA establishment registration (FEI; registration is not an FDA approval)
  • API manufacturing site GMP status
  • Additional GMP certification
  • Therapeutic Area
  • Country of manufacture
  • Manufacturing site country
  • Additional Information
No items found.

Prescription-only medicine. This information is intended for healthcare professionals and prospective business partners. It is not promotional material and is not intended for patients. For approved product information, consult the Georgian medicines register or contact us. To report a suspected side effect from a medicine supplied by Mermisi, please contact us.